Uppsala University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Uppsala University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013274
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Uppsala University is an educational service provider that offers education and research services. The university offers master programs in the areas of science and technology, arts, law, medicine, languages, social sciences and theology. It conducts pharmaceutical research projects in the areas of ageing related diseases, children’s diseases, cancer and other tumor diseases, cardiovascular diseases, behavioural science and ethics, biotechnology and bioinformatics, education research, psychiatry, and others. Uppsala University offers in-service training. The university conducts research in the areas of Biology, Computer Science, Physics, Earth Sciences, Chemistry, Mathematics and Engineering Sciences. It collaborates with the business community regarding both research and direct commercialization of results and ideas. Uppsala University is headquartered in Uppsala, Sweden.

Uppsala University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Uppsala University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Uppsala University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Uppsala University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Uppsala University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Uppsala University, Medical Devices Deals, 2011 to YTD 2017 9
Uppsala University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Uppsala University, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Beactica Raises Funds through Venture Financing 11
Partnerships 12
Double Bond Pharma Enters into Agreement with Uppsala University 12
Lidds Enters into Research Agreement with Uppsala University 13
Dicotyledon and Uppsala University Form Joint Venture 14
AstraZeneca Enters Into Joint Venture With Sanofi, University Of Cambridge, EPFL, And Universities Of Pavia And Uppsala 15
Licensing Agreements 17
Empros Pharma Enters into Licensing Agreement with Uppsala University 17
Uppsala University – Key Competitors 18
Uppsala University – Key Employees 19
Uppsala University – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Government and Public Interest 21
Nov 20, 2017: Oncotarget: Researchers Identify a Potential Molecular Trigger for Invasiveness in Prostate Cancer Cells 21
Oct 31, 2017: University of Copenhagen: Researchers map trends in drug development 22
Sep 27, 2017: Grants to 18 research projects that may lead to future scientific breakthroughs 23
Jul 11, 2017: Shortcut Method in Drug Development 26
May 19, 2017: Mislocalized calcium channel causes insulin secretion defect in diabetes 27
Apr 25, 2017: Potential new treatment for kidney failure in cancer patients 28
Jan 16, 2017: New Research Study Creates New Opportunities for Treating Brain Diseases 29
Product News 30
Nov 08, 2016: Acetium capsule prevents the exposure to carcinogenic acetaldehyde in patients with atrophy of the stomach mucosa 30
Aug 09, 2016: New approach to drug development with Upsalite 31
Jan 12, 2017: Inhibition of EZH2 might be new therapy of multiple myeloma 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Uppsala University, Pharmaceuticals & Healthcare, Key Facts 2
Uppsala University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Uppsala University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Uppsala University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Uppsala University, Deals By Therapy Area, 2011 to YTD 2017 8
Uppsala University, Medical Devices Deals, 2011 to YTD 2017 9
Uppsala University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Beactica Raises Funds through Venture Financing 11
Double Bond Pharma Enters into Agreement with Uppsala University 12
Lidds Enters into Research Agreement with Uppsala University 13
Dicotyledon and Uppsala University Form Joint Venture 14
AstraZeneca Enters Into Joint Venture With Sanofi, University Of Cambridge, EPFL, And Universities Of Pavia And Uppsala 15
Empros Pharma Enters into Licensing Agreement with Uppsala University 17
Uppsala University, Key Competitors 18
Uppsala University, Key Employees 19
Uppsala University, Subsidiaries 20

★海外企業調査レポート[Uppsala University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • iBio Inc (IBIO):企業の財務・戦略的SWOT分析
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It has its applications in ibiolaunch platform, which is a transformative technology for the production of monoclo …
  • Magellan Aerospace Corp:企業の戦略・SWOT・財務情報
    Magellan Aerospace Corp - Strategy, SWOT and Corporate Finance Report Summary Magellan Aerospace Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Trustees Australia Ltd:企業の戦略・SWOT・財務分析
    Trustees Australia Ltd - Strategy, SWOT and Corporate Finance Report Summary Trustees Australia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Miromatrix Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Miromatrix Medical Inc (Miromatrix Medical) is a biotechnology company engaged in the development extracellular matrix based medical devices in soft tissue reinforcement and advanced wound care. The company offers MIRODERM a porcine liver-derived noncrosslinked acellular biologic wound matri …
  • iPass Inc.:企業の戦略的SWOT分析
    iPass Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Epigenomics AG (ECX):製薬・医療:M&Aディール及び事業提携情報
    Summary Epigenomics AG (Epigenomics) is a molecular diagnostics company which develops and commercializes in-vitro diagnostic (IVD) tests for screening, early detection and diagnosis of cancer. Its lead product, Epi proColon is a blood-based test for rapid detection of colorectal cancer; and Epi pro …
  • Fulcrum Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Fulcrum Therapeutics Inc (Fulcrum Therapeutics) is a biotechnology company which focuses on the discovery and development of small molecule therapies to unlock the gene control. Its pipeline portfolio includes Fragile X syndrome (FXS) and facioscapulohumeral muscular dystrophy (FSHD). Fulcru …
  • Enel Americas S A (ENELAM):企業の財務・戦略的SWOT分析
    Enel Americas S A (ENELAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Schott AG:企業の戦略的SWOT分析
    Schott AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • RP Management LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary RP Management LLC (RP Management) is a life sciences financing company that offers biopharmaceutical products. The company’s products include thalomid, myozyme, lexiscan, rituxan, atripla, lyrica, prezista, letairis, januvia, onglyza, neupogen, rotateq, cubicin, savella, and others. It also …
  • E.ON SE:企業の発電所・SWOT分析2018
    E.ON SE - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives …
  • Sumitomo Dainippon Pharma Co., Ltd.:企業の戦略・SWOT・財務分析
    Sumitomo Dainippon Pharma Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Dainippon Pharma Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Advantest Corporation:企業の戦略・SWOT・財務分析
    Advantest Corporation - Strategy, SWOT and Corporate Finance Report Summary Advantest Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • MWH Global Inc:企業の戦略的SWOT分析
    MWH Global Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Google LLC:企業の戦略的SWOT分析
    Google LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Teva Pharmaceutical Industries Ltd (TEVA)-医療機器分野:企業M&A・提携分析
    Summary Teva Pharmaceutical Industries Ltd (Teva) carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines in central nervous system (CNS), respiratory, cancer, women’s health and other therapy areas. The company off …
  • Total System Services Inc (TSS):企業の財務・戦略的SWOT分析
    Total System Services Inc (TSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Clark Public Utilities:企業の戦略的SWOT分析
    Clark Public Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • NV Bekaert SA:企業の戦略・SWOT・財務情報
    NV Bekaert SA - Strategy, SWOT and Corporate Finance Report Summary NV Bekaert SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Kadmon Corp LLC-製薬・医療分野:企業M&A・提携分析
    Summary Kadmon Corp LLC (Kadmon) is a biopharmaceutical company that offers products and related services for the management and treatment of hepatitis C. The company also develops therapies for metabolic and serious diseases. Its products include ribavirin, USP Tablets, ribavirin capsules, phenterm …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆